logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Kymera Jumps on Rapid Eczema Trial Enrollment; Takeover Talk Swirls

Miracle or Bubble? These 2 Healthcare Stocks Doubled in Less Than a Month

Sep 21, 2025

Life Science

估值高企的礼来,凭什么用AI讲好新故事?

Why Is Overvalued Eli Lilly Using AI to Tell a New Story?

Sep 20, 2025

Life Science

获多个机构看好,CRISPR Therapeutics以多元管线引领基因编辑疗法

Highly Regarded by Multiple Institutions, CRISPR Therapeutics Leads Gene Editing Therapy with a Diverse Pipeline 

Sep 18, 2025

Life Science

Novo Nordisk Soars as Oral Wegovy Shows Promise in Weight Loss Trial

Novo Nordisk Soars as Oral Wegovy Shows Promise in Weight Loss Trial

Sep 18, 2025

Life Science

礼来口服减肥药数据强劲,巩固GLP-1市场领先地位

Eli Lilly’s Strong Oral Weight-Loss Drug Data Solidifies Its Leading Position in the GLP-1 Market

Sep 18, 2025

Life Science

Vertex Tops Q2 Estimates, But Investors Shift Focus to Crinetics Deal Integration

Roivant Stock Surges on Positive Phase 3 Dermatomyositis Trial

Sep 17, 2025

Life Science

后浪来袭,诺和诺德新一代减肥药疗效显著

The Tide of the Next Generation: Novo Nordisk’s New Weight-Loss Drug Shows Remarkable Efficacy

Sep 17, 2025

Life Science

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Eli Lilly Stock Hits High on Weight-Loss Drug Optimism and $5B Expansion

Sep 16, 2025

Life Science

分析师青睐,Scholar Rock股价跃升

Analyst Endorsement Fuels Scholar Rock’s Stock Surge

Sep 15, 2025

Life Science

CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance

Three CRISPR Stocks You Can’t Afford to Miss

Sep 14, 2025

Life Science

谁能挑战注射式减肥药?这家公司把赌注压在了药片上

Who Can Challenge Injectable Weight-Loss Drugs? This Company Is Betting on Pills

Sep 13, 2025

Life Science

2025年8月道琼斯指数涨幅榜:五只领涨股盘点

August 2025 Dow Jones Gainers: A Look at the Top Five Performing Stocks

Sep 12, 2025

Life Science, Technology

十年翻八倍,医疗机器人龙头股Intuitive Surgical仍具潜力?

Medical Robotics Leader Intuitive Surgical: Still Promising After an Eightfold Increase in a Decade?

Sep 12, 2025

Life Science

新品+独家合作:Hims & Hers拓展男性健康业务推动股价上涨

New + Exclusive Collaboration: Hims & Hers Expands Men’s Health Business to Drive Stock Price Increase

Sep 11, 2025

Life Science

医疗保健领域的“包租公”:亚历山大REIT提供6.2%的稳健收益

The “Rent Collector” in Healthcare: Alexandria REIT Offers a Solid 6.2% Yield

Sep 9, 2025

Life Science

暴跌47%后,联合健康的“护城河”还管用吗?

After a 47% Plunge, Is UnitedHealth’s ‘Moat’ Still Effective?

Sep 9, 2025

Life Science

减肥药市场生变?诺和诺德手握口服“王牌”

Weight Loss Drug Market Faces Changes? Novo Nordisk Holds the Oral “Key”

Sep 9, 2025

Life Science

Wall Street’s Big UNH Split: Berkshire Exits, Goldman Sees Solid Upside

AbbVie’s ‘Patent Playbook’ Powers 494% Return, Fuels Dividend Surge

Sep 8, 2025

Life Science

  • ‹‹ Previous
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada